Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) was the recipient of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 4,380,000 shares, a growth of 55.9% from the October 31st total of 2,810,000 shares. Currently, 8.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 985,600 shares, the short-interest ratio is presently 4.4 days.
Institutional Investors Weigh In On Aurora Cannabis
A number of institutional investors have recently made changes to their positions in ACB. Virtu Financial LLC purchased a new stake in shares of Aurora Cannabis in the 1st quarter valued at $727,000. Cetera Advisors LLC purchased a new stake in Aurora Cannabis during the 1st quarter valued at $59,000. Baader Bank Aktiengesellschaft boosted its position in Aurora Cannabis by 121.1% during the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock valued at $100,000 after buying an additional 12,481 shares during the period. TD Asset Management Inc purchased a new stake in Aurora Cannabis during the 2nd quarter valued at $255,000. Finally, Headlands Technologies LLC boosted its position in Aurora Cannabis by 98.8% during the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after buying an additional 37,269 shares during the period. Hedge funds and other institutional investors own 47.63% of the company’s stock.
Aurora Cannabis Price Performance
Shares of Aurora Cannabis stock opened at $4.54 on Friday. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The stock has a market capitalization of $248.97 million, a price-to-earnings ratio of -5.97 and a beta of 1.87. The company has a fifty day moving average of $5.29 and a 200-day moving average of $5.74. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- The 3 Best Blue-Chip Stocks to Buy Now
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Utilities Stocks Explained – How and Why to Invest in Utilities
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- EV Stocks and How to Profit from Them
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.